Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB 2 receptor inverse agonists

Chemistry and Biology

Volumn 18, Issue 8, 2011, Pages 1053-1064

  Schuehly, Wolfgang ^a,b   Paredes, Juan Manuel Viveros ^a   Kleyer, Jonas ^a   Huefner, Antje ^b   Anavi Goffer, Sharon ^c,d   Raduner, Stefan ^e   Altmann, Karl Heinz ^e   Gertsch, Jürg ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ARIEL UNIVERSITY   (Israel)

^e ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 O METHYLHONOKIOL; 4-O-METHYLHONOKIOL; BIPHENYL; BIPHENYL DERIVATIVE; CALCIUM; CANNABINOID 2 RECEPTOR; CYCLIC AMP; ENDOCANNABINOID; LIGNAN; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; MACROPHAGE; METABOLISM; MIGRATION INHIBITION; MONOCYTE; MOUSE; OSTEOCLAST; PLANT;

ANIMALS; BIPHENYL COMPOUNDS; CALCIUM; CELL LINE; CELL MIGRATION INHIBITION; CELLS, CULTURED; CYCLIC AMP; ENDOCANNABINOIDS; HUMANS; LIGNANS; MACROPHAGES; MICE; MONOCYTES; OSTEOCLASTS; OSTEOGENESIS; PLANT EXTRACTS; PLANTS; RECEPTOR, CANNABINOID, CB2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79961228829     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2011.05.012     Document Type: Article

References (53)

1. K.S. Ahn, G. Sethi, S. Shishodia, B. Sung, J.L. Arbiser, and B.B. Aggarwal Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway Mol. Cancer Res. 4 2006 621 633 (Pubitemid 44497215)
2. 2: a cannabinoid receptor with an identity crisis Br. J. Pharmacol. 160 2010 467 479
3. I.A. Bab Regulation of skeletal remodeling by the endocannabinoid system Ann. N. Y. Acad. Sci. 1116 2007 414 422 (Pubitemid 350274318)
4. I. Bab, and A. Zimmer Cannabinoid receptors and the regulation of bone mass Br. J. Pharmacol. 153 2008 182 188
5. I. Bab, A. Zimmer, and E. Melamed Cannabinoids and the skeleton: from marijuana to reversal of bone loss Ann. Med. 41 2009 560 567
6. R. Balga, A. Wetterwald, J. Portenier, S. Dolder, C. Mueller, and W. Hofstetter Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro Bone 39 2006 325 335 (Pubitemid 43851380)
7. B. Bosier, G.G. Muccioli, E. Hermans, and D.M. Lambert Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities Biochem. Pharmacol. 80 2010 1 12
8. W.J. Boyle, W.S. Simonet, and D.L. Lacey Osteoclast differentiation and activation Nature 423 2003 337 342 (Pubitemid 40852708)
9. N.E. Buckley The peripheral cannabinoid receptor knockout mice: an update Br. J. Pharmacol. 153 2008 309 318
10. A. Chicca, S. Raduner, F. Pellati, T. Strompen, K.H. Altmann, R. Schoop, and J. Gertsch Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts Int. Immunopharmacol. 9 2009 850 858
11. L. Costantino, and D. Barlocco Privileged structures as leads in medicinal chemistry Curr. Med. Chem. 13 2006 65 85
12. V. Di Marzo The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation Pharmacol. Res. 60 2009 77 84
13. J. Gertsch Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action? Commun. Integr. Biol. 1 2008 26 28
14. J. Gertsch, M. Leonti, S. Raduner, I. Racz, J.Z. Chen, X.Q. Xie, K.H. Altmann, M. Karsak, and A. Zimmer Beta-caryophyllene is a dietary cannabinoid Proc. Natl. Acad. Sci. USA 105 2008 9099 9104
15. J. Gertsch, R.G. Pertwee, and V. Di Marzo Phytocannabinoids beyond the Cannabis plant - do they exist? Br. J. Pharmacol. 160 2010 523 529
16. M. Gokoh, S. Kishimoto, S. Oka, and T. Sugiura 2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells Biol. Pharm. Bull. 30 2007 1199 1205 (Pubitemid 47037636)
17. L.O. Hanus, and R. Mechoulam Novel natural and synthetic ligands of the endocannabinoid system Curr. Med. Chem. 17 2010 1341 1359
18. S. Hasegawa, T. Yonezawa, J.Y. Ahn, B.Y. Cha, T. Teruya, M. Takami, K. Yagasaki, K. Nagai, and J.T. Woo Honokiol inhibits osteoclast differentiation and function in vitro Biol. Pharm. Bull. 33 2010 487 492
19. A.I. Idris, and S.H. Ralston Cannabinoids and bone: friend or foe? Calcif. Tissue Int. 87 2010 285 297
20. A.I. Idris, R.J. van 't Hof, I.R. Greig, S.A. Ridge, D. Baker, R.A. Ross, and S.H. Ralston Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors Nat. Med. 11 2005 774 779 (Pubitemid 41021210)
21. A.I. Idris, A. Sophocleous, E. Landao-Bassonga, R.J. van't Hof, and S.H. Ralston Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor Endocrinology 149 2008 5619 5626
22. A.I. Idris, E. Landao-Bassonga, and S.H. Ralston The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo Bone 46 2010 1089 1099
23. A.I. Idris, E. Coste, I.R. Greig, S.H. Ralston, and R.J. van't Hof The biphenyl-carboxylate derivative ABD328 is a novel orally active antiresorptive agent Calcif. Tissue Int. 87 2010 525 532
24. M. Karsak, M. Cohen-Solal, J. Freudenberg, A. Ostertag, C. Morieux, U. Kornak, J. Essig, E. Erxlebe, I. Bab, and C. Kubisch Cannabinoid receptor type 2 gene is associated with human osteoporosis Hum. Mol. Genet. 14 2005 3389 3396 (Pubitemid 41672123)
25. C.A. Lunn, J.S. Fine, A. Rojas-Triana, J.V. Jackson, X. Fan, T.T. Kung, W. Gonsiorek, M.A. Schwarz, B. Lavey, and J.A. Kozlowski A novel cannabinoid peripheral cannabinoid receptor-selective inverse agonist blocks leukocyte recruitment in vivo J. Pharmacol. Exp. Ther. 316 2006 780 788 (Pubitemid 43131006)
26. C.A. Lunn, J. Fine, A. Rojas-Triana, J.V. Jackson, B. Lavey, J.A. Kozlowski, R.W. Hipkin, D.J. Lundell, and L. Bober Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss Immunopharmacol. Immunotoxicol. 29 2007 387 401 (Pubitemid 350261182)
27. 2 receptor inverse agonists Br. J. Pharmacol. 153 2008 226 239
28. K. Mackie, and N. Stella Cannabinoid receptors and endocannabinoids: evidence for new players AAPS J. 8 2006 E298 E306
29. 2 receptor coupled to chimeric Galpha(qi5) and Galpha(qo5) proteins Eur. J. Pharmacol. 603 2009 12 21
30. Martinez, M. (1959). Las plantas medicinales de Mexico. Mexico City: Editorial Botas, 4th ed. pp. 343-347.
31. I. Matias, P. Pochard, P. Orlando, M. Salzet, J. Pestel, and V. Di Marzo Presence and regulation of the endocannabinoid system in human dendritic cells Eur. J. Biochem. 269 2002 3771 3778 (Pubitemid 34989126)
32. V. Mellado, M.A. Chavez Soto, and X. Lozoya Pharmacological screening of the aqueous extracts of Magnolia grandiflora L Arch. Invest. Med. (Mex.) 11 1980 335 346
33. G.G. Muccioli Endocannabinoid biosynthesis and inactivation, from simple to complex Drug Discov. Today 15 2010 474 483
34. T. Nakashima, and H. Takayanagi Osteoclasts and the immune system J. Bone Miner. Metab. 27 2009 519 529
35. 2+-NFATc1 signaling is an essential axis of osteoclast differentiation Immunol. Rev. 231 2009 241 256
36. 2, regulates bone mass Proc. Natl. Acad. Sci. USA 103 2006 696 701 (Pubitemid 43153088)
37. i protein-cyclin D1 axis in osteoblasts J. Bone Miner. Res. 26 2011 308 316
38. S. Oka, S. Ikeda, S. Kishimoto, M. Gokoh, S. Yanagimoto, K. Waku, and T. Sugiura 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils J. Leukoc. Biol. 76 2004 1002 1009 (Pubitemid 39458711)
39. R.G. Pertwee, A.C. Howlett, M.E. Abood, S.P. Alexander, V. Di Marzo, M.R. Elphick, P.J. Greasley, H.S. Hansen, G. Kunos, and K. Mackie International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB Pharmacol. Rev. 62 2010 588 631
40. S. Raduner, A. Majewska, J.Z. Chen, X.Q. Xie, J. Hamon, B. Faller, K.H. Altmann, and J. Gertsch Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects J. Biol. Chem. 281 2006 14192 14206 (Pubitemid 43848347)
41. 2 cannabinoid receptor J. Pharmacol. Exp. Ther. 284 1998 644 650 (Pubitemid 28086654)
42. R.A. Ross The enigmatic pharmacology of GPR55 Trends Pharmacol. Sci. 30 2009 156 163
43. F. Rossi, D. Siniscalco, L. Luongo, L. De Petrocellis, G. Bellini, S. Petrosino, M. Torella, C. Santoro, B. Nobili, and S. Perrotta The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption Bone 44 2009 476 484
44. 4-formation Bioorg. Med. Chem. 17 2009 4459 4465
45. 2 cannabinoid receptors J. Pharmacol. Exp. Ther. 314 2005 868 875 (Pubitemid 41043873)
46. 2 receptors J. Pharmacol. Exp. Ther. 315 2005 828 838 (Pubitemid 41509039)
47. S.A. Stoch, and J.A. Wagner Cathepsin K inhibitors: a novel target for osteoporosis therapy Clin. Pharmacol. Ther. 83 2008 172 176
48. 2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells J. Biol. Chem. 275 2000 605 612 (Pubitemid 30039024)
49. M. Susa, N.H. Luong-Nguyen, D. Cappellen, N. Zamurovic, and R. Gamse Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay J. Transl. Med. 16 2004 2 6
50. C.E. Turner, M.A. Elsohly, and E.G. Boeren Constituents of Cannabis sativa L. XVII. A review of the natural constituents J. Nat. Prod. 43 1980 169 234 (Pubitemid 10020139)
51. R.J. Van't Hof, A.I. Idris, S.A. Ridge, J. Dunford, I.R. Greig, and S.H. Ralston Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors J. Bone Miner. Res. 19 2004 1651 1660 (Pubitemid 41094328)
52. L. Vollner, D. Bieniek, and F. Korte [Hashish. XX. Cannabidivarin, a new hashish constituent] Tetrahedron Lett. 3 1969 145 147
53. L.S. Whyte, E. Ryberg, N.A. Sims, S.A. Ridge, K. Mackie, P.J. Greasley, R.A. Ross, and M.J. Rogers The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo Proc. Natl. Acad. Sci. USA 106 2009 16511 16516